{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:08:55Z","timestamp":1790809735876,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s41588-019-0440-9","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T12:03:27Z","timestamp":1561723407000},"page":"1123-1130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["The genetic evolution of metastatic uveal melanoma"],"prefix":"10.1038","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2999-9706","authenticated-orcid":false,"given":"A. Hunter","family":"Shain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5635-9109","authenticated-orcid":false,"given":"Darwin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Vemula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingly F.","family":"Weier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-6798","authenticated-orcid":false,"given":"Karin","family":"Wadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1836-6062","authenticated-orcid":false,"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-1460","authenticated-orcid":false,"given":"Jens F.","family":"Kiilgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"440_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian, B. C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu. Rev. Pathol. 9, 239\u2013271 (2014).","journal-title":"Annu. Rev. Pathol."},{"key":"440_CR2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh, A. D. & Topham, A. Survival rates with uveal melanoma in the United States: 1973\u20131997. Ophthalmology 110, 962\u2013965 (2003).","journal-title":"Ophthalmology"},{"key":"440_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh, A. D., Turell, M. E. & Topham, A. K. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118, 1881\u20131885 (2011).","journal-title":"Ophthalmology"},{"key":"440_CR4","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala, E., M\u00e4kitie, T. & Kivel\u00e4, T. Very long-term prognosis of patients with malignant uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44, 4651\u20134659 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"440_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1167\/iovs.16-20212","volume":"58","author":"M Dogrus\u00f6z","year":"2017","unstructured":"Dogrus\u00f6z, M. et al. The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status. Invest. Ophthalmol. Vis. Sci. 58, 833\u2013842 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"440_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","volume":"148","author":"JJ Augsburger","year":"2009","unstructured":"Augsburger, J. J., Corr\u00eaa, Z. M. & Shaikh, A. H. Effectiveness of treatments for metastatic uveal melanoma. Am. J. Ophthalmol. 148, 119\u2013127 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"440_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell 32, 204\u2013220.e15 (2017).","journal-title":"Cancer Cell"},{"key":"440_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","volume":"45","author":"JW Harbour","year":"2013","unstructured":"Harbour, J. W. et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. 45, 133\u2013135 (2013).","journal-title":"Nat. Genet."},{"key":"440_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin, M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. 45, 933\u2013936 (2013).","journal-title":"Nat. Genet."},{"key":"440_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010).","journal-title":"Science"},{"key":"440_CR11","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin, J. A. et al. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135\u20132147 (2005).","journal-title":"N. Engl. J. Med."},{"key":"440_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CDV Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk, C. D. V. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599\u2013602 (2009).","journal-title":"Nature"},{"key":"440_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191\u20132199 (2010).","journal-title":"N. Engl. J. Med."},{"key":"440_CR14","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson, P. et al. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget 7, 4624\u20134631 (2016).","journal-title":"Oncotarget"},{"key":"440_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ng.3549","volume":"48","author":"AR Moore","year":"2016","unstructured":"Moore, A. R. et al. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat. Genet. 48, 675\u2013680 (2016).","journal-title":"Nat. Genet."},{"key":"440_CR16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner, T. et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat. Genet. 43, 1018\u20131021 (2011).","journal-title":"Nat. Genet."},{"key":"440_CR17","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","volume":"99","author":"B Royer-Bertrand","year":"2016","unstructured":"Royer-Bertrand, B. et al. Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing. Am. J. Hum. Genet. 99, 1190\u20131198 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"440_CR18","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.ophtha.2018.03.047","volume":"125","author":"M Bagger","year":"2018","unstructured":"Bagger, M. et al. Long-term metastatic risk after biopsy of posterior uveal melanoma. Ophthalmology 125, 1969\u20131976 (2018).","journal-title":"Ophthalmology"},{"key":"440_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-68","volume":"4","author":"M Kerick","year":"2011","unstructured":"Kerick, M. et al. Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med. Genomics 4, 68 (2011).","journal-title":"BMC Med. Genomics"},{"key":"440_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02428-w","volume":"9","author":"MG Field","year":"2018","unstructured":"Field, M. G. et al. Punctuated evolution of canonical genomic aberrations in uveal melanoma. Nat. Commun. 9, 116 (2018).","journal-title":"Nat. Commun."},{"key":"440_CR21","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"440_CR22","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/bjc.2017.259","volume":"117","author":"MJC Vader","year":"2017","unstructured":"Vader, M. J. C. et al. GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi. Br. J. Cancer 117, 884\u2013887 (2017).","journal-title":"Br. J. Cancer"},{"key":"440_CR23","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1158\/0008-5472.CAN-14-3229","volume":"75","author":"JL-Y Huang","year":"2015","unstructured":"Huang, J. L.-Y., Urtatiz, O. & Van Raamsdonk, C. D. Oncogenic G protein GNAQ induces uveal melanoma and intravasation in mice. Cancer Res. 75, 3384\u20133397 (2015).","journal-title":"Cancer Res."},{"key":"440_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/archophthalmol.2011.181","volume":"129","author":"SA Callejo","year":"2011","unstructured":"Callejo, S. A., Dopierala, J., Coupland, S. E. & Damato, B. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch. Ophthalmol. 129, 958\u2013960 (2011).","journal-title":"Arch. Ophthalmol."},{"key":"440_CR25","doi-asserted-by":"crossref","first-page":"37824","DOI":"10.18632\/oncotarget.5637","volume":"6","author":"MJ de Lange","year":"2015","unstructured":"de Lange, M. J. et al. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma. Oncotarget 6, 37824\u201337835 (2015).","journal-title":"Oncotarget"},{"key":"440_CR26","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1167\/iovs.15-16822","volume":"56","author":"N Singh","year":"2015","unstructured":"Singh, N., Singh, A. D. & Hide, W. Inferring an evolutionary tree of uveal melanoma from genomic copy number aberrations. Invest. Ophthalmol. Vis. Sci. 56, 6801\u20136809 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"440_CR27","doi-asserted-by":"publisher","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","volume":"8","author":"AH Shain","year":"2013","unstructured":"Shain, A. H. & Pollack, J. R. The spectrum of SWI\/SNF mutations, ubiquitous in human cancers. PLoS ONE 8, e55119 (2013).","journal-title":"PLoS ONE"},{"key":"440_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7051","volume":"6","author":"D Zingg","year":"2015","unstructured":"Zingg, D. et al. The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nat. Commun. 6, 6051 (2015).","journal-title":"Nat. Commun."},{"key":"440_CR29","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","volume":"21","author":"LM LaFave","year":"2015","unstructured":"LaFave, L. M. et al. Loss of BAP1 function leads to EZH2-dependent transformation. Nat. Med. 21, 1344\u20131349 (2015).","journal-title":"Nat. Med."},{"key":"440_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson, B. G. et al. Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell 18, 316\u2013328 (2010).","journal-title":"Cancer Cell"},{"key":"440_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2013-303867","volume":"98","author":"N Cassoux","year":"2014","unstructured":"Cassoux, N. et al. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma. Br. J. Ophthalmol. 98, 769\u2013774 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"440_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581\u2013594.e12 (2018).","journal-title":"Cell"},{"key":"440_CR33","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"440_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.aat7171","volume":"361","author":"JG Reiter","year":"2018","unstructured":"Reiter, J. G. et al. Minimal functional driver gene heterogeneity among untreated metastases. Science 361, 1033\u20131037 (2018).","journal-title":"Science"},{"key":"440_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(90)90523-H","volume":"61","author":"R Bremner","year":"1990","unstructured":"Bremner, R. & Balmain, A. Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61, 407\u2013417 (1990).","journal-title":"Cell"},{"key":"440_CR36","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain, A. H. et al. The genetic evolution of melanoma from precursor lesions. N. Engl. J. Med. 373, 1926\u20131936 (2015).","journal-title":"N. Engl. J. Med."},{"key":"440_CR37","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ng.3382","volume":"47","author":"AH Shain","year":"2015","unstructured":"Shain, A. H. et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat. Genet. 47, 1194\u20131199 (2015).","journal-title":"Nat. Genet."},{"key":"440_CR38","doi-asserted-by":"publisher","unstructured":"Shain, H. Compiled genetic summary of the evolution of 35 metastatic uveal melanomas. figshare \n                    https:\/\/doi.org\/10.6084\/m9.figshare.6845675.v1\n                    \n                   (2019).","DOI":"10.6084\/m9.figshare.6845675.v1"},{"key":"440_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","volume":"34","author":"AH Shain","year":"2018","unstructured":"Shain, A. H. et al. Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer Cell 34, 45\u201355.e4 (2018).","journal-title":"Cancer Cell"},{"key":"440_CR40","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten, J. P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41588-019-0440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-019-0440-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41588-019-0440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:22:22Z","timestamp":1684606942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-019-0440-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1038\/s41588-019-0440-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736064049.793566602","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.736064049.793585167","asserted-by":"object"}]},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.C.B. is a consultant for Lilly Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}